Boston Scientific Corporation ranks near the peer group median, with valuation as the main structural strength, while profitability is less supportive than the other dimensions. The market setup has weakened, with clear trend damage and relative performance under pressure. Price action is lagging the structural profile — current market behavior is not yet confirming the structural position.
Peer-relative scores, weakest to strongest
Boston Scientific develops and manufactures medical devices for a range of medical specialties, including cardiology and electrophysiology.
The market prices Boston Scientific on deteriorating peer-relative quality and margin risks, not on durable growth strength. With an operating margin of 15.2% (well below peer median in FY25) and ROIC at 6.1% (trails sector leaders over past two years), Boston Scientific consistently trades at a discount as the market reacts to any sign of lagging profitability by marking down the stock—pricing in heightened sensitivity to margin defense and competitiveness, especially as headwinds and competitive pressure in key segments like electrophysiology and WATCHMAN continue. In medtech, sustained margins and innovation leadership are critical, and Boston Scientific is losing ground to specialized competitors such as Abbott and Medtronic. The result is a persistent valuation discount, as the market focuses on peer weakness and segment risks. Only a clear margin recovery and sustained market share gains in core segments would break the peer-discount framing.
Break down BSX's position across all dimensions with the full interactive tool.
This analysis is rule-based and descriptive. Peer-relative scores are derived from functional peer group comparisons using publicly available financial data. Scores reflect structural positioning only and do not constitute investment advice, a buy or sell recommendation, or a forecast of future performance. AssetNext peer scores are recalculated periodically as new data becomes available.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.